bioRxivNeurosciencePreprint
Synergistic MAPT mutations as a platform to uncover modifiers of tau pathogenesis
Miles R. BryaniD, Michael Almeida, Kyle Pellegrino, Carli K. OplandiD, Ethan Paulakonis, Jake McGillion-Moore, Hanna TrzeciakiewicziD, Diamond P. King, Tian XuiD, Jui‐Heng TsengiD, Jonathan Cummings SchisleriD, Nicholas G Brown, Ben A. BahriD, Todd J CoheniD
Abstract
The natively unfolded tau (MAPT) protein is extremely soluble, which poses challenges when modeling neurofibrillary tangle (NFT) pathology in Alzheimers disease (AD). To overcome this hurdle, we combined P301L and S320F mutations (PL-SF) to generate a rapid and reliable tau pathology platform to expedite the discovery of factors that modify tau aggregation. Using this model, we evaluated heat-shock proteins (Hsp), which have been linked to tau pathology, but whose role in AD remains enigmatic and controversial. In primary neurons, expression of Hsp70, but not Hsc70 or Hsp90, exacerbated tau aggregation. Conversely, lowering Hsp70 or employing a chaperone-deficient tau mutant (PL-SF-4{Delta}) reduced tau phosphorylation and abrogated tau aggregation, highlighting Hsp70 as a key driver of tau aggregation. Hsp70 foci clustered within and surrounding neuritic plaques and NFTs in post-mortem AD brain. Functionally, mature aggregate-bearing neurons showed deficits in neuronal firing and network communication, which were restored by chaperone-binding deficient tau variants that abrogated tau pathology. This study provides a powerful cell-intrinsic model for accelerated tau aggregation, which can be harnessed to identify potent regulators of tau aggregation as promising therapeutic targets.
- organism: human
- assay: protein structure
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hsp multichaperone complex buffers pathologically modified Tau
A. Moll, L.-M. Ramirez, … M. Zweckstetter·bioRxiv·Mar 18, 2022
- Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
- Function within Disorder: Small heat shock proteins use different functional regions to chaperone tau aggregation
Mia Cervantes, Maria K. Janowska, … Rachel E. Klevit·Protein SciencePeer-reviewed·Sep 16, 2026
- Synthetic chaperone based on Hsp90-Tau interaction inhibits pathological Tau aggregation and rescues physiological Tau-Microtubule interaction
Davide Di Lorenzo, Nicolò Bisi, … Sandrine Ongeri·Nature CommunicationsPeer-reviewed·Oct 1, 2025
- In vitro tau aggregation inducer molecules influence the effects of MAPT mutations on aggregation dynamics
D. J. Ingham, K. M. Hillyer, … T. C. Gamblin·bioRxiv·Aug 6, 2021
- p23-FKBP51 chaperone complex regulates tau aggregation
P. Chakraborty, M. Zweckstetter·bioRxiv·Dec 27, 2023